Released on 15/09/2018

Key Learning Points

  • Atrial fibrillation
  • Atrial fibrillation: clinical presentation
  • New oral anticoagulants
  • Synchronized cardioversion
  • The CHA2DS2-VASc score
  • The HAS-BLED score


1. AMERENA JV, WALTERS TE, MIRZAEE S, KALMAN JM. Update on the management of atrial fibrillation. Med J Aust [online] 2013 Nov 4, 199(9):592-7 [viewed 19 October 2016] Available from:
2. WYNDHAM CR. Atrial Fibrillation: The Most Common Arrhythmia Tex Heart Inst J [online] 2000, 27(3):257-267 [viewed 19 October 2016] Available from:
3. CUTUGNO CL. CE: Atrial Fibrillation: Updated Management Guidelines and Nursing Implications. Am J Nurs [online] 2015 May, 115(5):26-38; quiz 39, 49 [viewed 19 October 2016] Available from:
4. JANUARY CT, WANN LS, ALPERT JS, CALKINS H, CIGARROA JE, CLEVELAND JC JR, CONTI JB, ELLINOR PT, EZEKOWITZ MD, FIELD ME, MURRAY KT, SACCO RL, STEVENSON WG, TCHOU PJ, TRACY CM, YANCY CW, ACC/AHA TASK FORCE MEMBERS. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation [online] 2014 Dec 2, 130(23):e199-267 [viewed 19 October 2016] Available from:
5. RAMOS-ESQUIVEL A. Monitoring anticoagulant therapy with new oral agents World J Methodol [online] 2015 Dec 26, 5(4):212-215 [viewed 19 October 2016] Available from:
6. HIRSH J, FUSTER V, ANSELL J, HALPERIN JL, AMERICAN HEART ASSOCIATION, AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION. American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. Circulation [online] 2003 Apr 1, 107(12):1692-711 [viewed 19 October 2016] Available from:
7. KOVACS RJ, FLAKER GC, SAXONHOUSE SJ, DOHERTY JU, BIRTCHER KK, CUKER A, DAVIDSON BL, GIUGLIANO RP, GRANGER CB, JAFFER AK, MEHTA BH, NUTESCU E, WILLIAMS KA. Practical management of anticoagulation in patients with atrial fibrillation. J Am Coll Cardiol [online] 2015 Apr 7, 65(13):1340-60 [viewed 19 October 2016] Available from:
8. CROWTHER MA, WARKENTIN TE. Bleeding risk and the management of bleeding complications in patients undergoing anticoagulant therapy: focus on new anticoagulant agents. Blood [online] 2008 May 15, 111(10):4871-9 [viewed 19 October 2016] Available from:
9. WYSOKINSKI WE, MCBANE RD 2ND. Periprocedural bridging management of anticoagulation. Circulation [online] 2012 Jul 24, 126(4):486-90 [viewed 19 October 2016] Available from:
10. VAN RYN J, STANGIER J, HAERTTER S, LIESENFELD K, WIENEN W, FEURING M, et al. Dabigatran etexilate - a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity. Thrombosis and Haemostasis [online]. 2010 [viewed 19 October 2016];103(6):1116-1127. Available from:
11. KIRCHHOF P, BENUSSI S, KOTECHA D, AHLSSON A, ATAR D, CASADEI B, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. European Heart Journal. 2016;37(38):2893-2962. Available from: